<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="iso-abbrev">Nucleic Acids Res</journal-id>
    <journal-id journal-id-type="publisher-id">nar</journal-id>
    <journal-title-group>
      <journal-title>Nucleic Acids Research</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0305-1048</issn>
    <issn pub-type="epub">1362-4962</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9825455</article-id>
    <article-id pub-id-type="pmid">36243970</article-id>
    <article-id pub-id-type="doi">10.1093/nar/gkac873</article-id>
    <article-id pub-id-type="publisher-id">gkac873</article-id>
    <article-categories>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI00010</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Database Issue</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>HProteome-BSite: predicted binding sites and ligands in human 3D proteome</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Sim</surname>
          <given-names>Jiho</given-names>
        </name>
        <aff><institution>Department of Chemistry, Seoul National University</institution>, <addr-line>Seoul</addr-line> 08826, <country country="KR">Republic of Korea</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kwon</surname>
          <given-names>Sohee</given-names>
        </name>
        <aff><institution>Department of Chemistry, Seoul National University</institution>, <addr-line>Seoul</addr-line> 08826, <country country="KR">Republic of Korea</country></aff>
        <aff><institution>Galux Inc</institution>, <addr-line>Gwanak-gu</addr-line>, <addr-line>Seoul</addr-line> 08738, <country country="KR">Republic of Korea</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1419-9888</contrib-id>
        <name>
          <surname>Seok</surname>
          <given-names>Chaok</given-names>
        </name>
        <!--chaok@snu.ac.kr-->
        <aff><institution>Department of Chemistry, Seoul National University</institution>, <addr-line>Seoul</addr-line> 08826, <country country="KR">Republic of Korea</country></aff>
        <aff><institution>Galux Inc</institution>, <addr-line>Gwanak-gu</addr-line>, <addr-line>Seoul</addr-line> 08738, <country country="KR">Republic of Korea</country></aff>
        <xref rid="COR1" ref-type="corresp"/>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="COR1">To whom correspondence should be addressed. Tel: +82 2 880 9197; Fax: +82 2 889 1568; Email: <email>chaok@snu.ac.kr</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>06</day>
      <month>1</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2022-10-16">
      <day>16</day>
      <month>10</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>16</day>
      <month>10</month>
      <year>2022</year>
    </pub-date>
    <volume>51</volume>
    <issue>D1</issue>
    <fpage>D403</fpage>
    <lpage>D408</lpage>
    <history>
      <date date-type="accepted">
        <day>29</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="rev-recd">
        <day>20</day>
        <month>9</month>
        <year>2022</year>
      </date>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022. Published by Oxford University Press on behalf of Nucleic Acids Research.</copyright-statement>
      <copyright-year>2023</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact <email>journals.permissions@oup.com</email></license-p>
      </license>
    </permissions>
    <self-uri xlink:href="gkac873.pdf"/>
    <abstract>
      <title>Abstract</title>
      <p>Atomic-level knowledge of protein-ligand interactions allows a detailed understanding of protein functions and provides critical clues to discovering molecules regulating the functions. While recent innovative deep learning methods for protein structure prediction dramatically increased the structural coverage of the human proteome, molecular interactions remain largely unknown. A new database, HProteome-BSite, provides predictions of binding sites and ligands in the enlarged 3D human proteome. The model structures for human proteins from the AlphaFold Protein Structure Database were processed to structural domains of high confidence to maximize the coverage and reliability of interaction prediction. For ligand binding site prediction, an updated version of a template-based method GalaxySite was used. A high-level performance of the updated GalaxySite was confirmed. HProteome-BSite covers 80.74% of the UniProt entries in the AlphaFold human 3D proteome. Predicted binding sites and binding poses of potential ligands are provided for effective applications to further functional studies and drug discovery. The HProteome-BSite database is available at <ext-link xlink:href="https://galaxy.seoklab.org/hproteome-bsite/database" ext-link-type="uri">https://galaxy.seoklab.org/hproteome-bsite/database</ext-link> and is free and open to all users.</p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>National Research Foundation of Korea</institution>
            <institution-id institution-id-type="DOI">10.13039/501100003725</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>2020M3A9G7103933</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Institute of Information &amp; communications Technology Planning &amp; Evaluation (IITP)</institution>
          </institution-wrap>
        </funding-source>
        <award-id>2021-0-02068</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Samsung Science and Technology Foundation</institution>
            <institution-id institution-id-type="DOI">10.13039/501100014364</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>SSTF-BA1901-08</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="6"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="SEC1">
    <title>INTRODUCTION</title>
    <p>Recent innovative deep learning methods for protein structure prediction have dramatically increased the structural coverage of the human proteome (<xref rid="B1" ref-type="bibr">1</xref>,<xref rid="B2" ref-type="bibr">2</xref>). The AlphaFold Protein Structure Database (AFDB, <ext-link xlink:href="https://alphafold.ebi.ac.uk" ext-link-type="uri">https://alphafold.ebi.ac.uk</ext-link>) allows free access to the predicted structures by AlphaFold (AF) (<xref rid="B1" ref-type="bibr">1</xref>) for proteosomes of 20 organisms, including human (<xref rid="B3" ref-type="bibr">3</xref>). AFDB, along with AF itself, has served as a resource for extensive research. For example, Kincore, a program for protein kinase structure labelling, was applied to AF-predicted human kinase domain structures (<xref rid="B4" ref-type="bibr">4</xref>). APPRIS, a database of principal protein isoforms annotation, was updated by including AFDB to predict the splicing effect on protein structures (<xref rid="B5" ref-type="bibr">5</xref>).</p>
    <p>Many proteins function by interacting with small bioactive ligands. Knowledge of the protein-ligand interactions, i.e. the identity of ligands interacting with the given protein, ligand binding sites, and 3D binding poses, can serve as a basis for protein functional studies and drug discovery (<xref rid="B6" ref-type="bibr">6</xref>). Information on the interactions of protein and ligand molecules has been collected from the experimentally resolved structures in Protein Data Bank (PDB) (<xref rid="B7" ref-type="bibr">7</xref>) in various databases including PDBbind (<xref rid="B8" ref-type="bibr">8</xref>), BioLip (<xref rid="B9" ref-type="bibr">9</xref>), Binding MOAD (<xref rid="B10" ref-type="bibr">10</xref>), and sc-PDB (<xref rid="B11" ref-type="bibr">11</xref>). Databases like PocketDB (<xref rid="B12" ref-type="bibr">12</xref>) and ProBis-Dock (<xref rid="B13" ref-type="bibr">13</xref>) augmented the information on interaction by including predicted pockets for protein structures deposited in PDB.</p>
    <p>Despite the continuous increase in PDB, many proteins still lack binding information. Recently, databases that provide ligand binding information on the enlarged structure database AFDB have been reported. For example, AlphaFill (<xref rid="B14" ref-type="bibr">14</xref>) reports structurally transplanted small molecules to AF structures from template protein-ligand complex structures selected based on sequence identity. The transplanted compounds are limited in diversity, including 400 ligands, cofactors, and metal ions that are commonly found in PDB. CavitySpace (<xref rid="B15" ref-type="bibr">15</xref>) provides predicted ligand binding sites of human AF model structures using a geometry-based binding site prediction method that detects potential cavities on protein surfaces. PrankWeb (<xref rid="B16" ref-type="bibr">16</xref>) and ScanNet (<xref rid="B17" ref-type="bibr">17</xref>) are examples of web servers that allow the prediction of protein binding sites on AF structures. PrankWeb also allows bulk download of precomputed predictions on AF structures. The machine-learning-based (PrankWeb) and geometry-based (CavitySpace and ScanNet) prediction methods do not provide potential binding partners. All of the previous databases and web servers use the raw model structures of AFDB. However, the structures in AFDB show varying model accuracy within each model, containing low-quality regions which can affect the reliability of binding site prediction.</p>
    <p>Here, we present HProteome-BSite, a new database of predicted binding sites, putative ligands, and 3D binding poses for the 3D human proteome of AFDB. Binding sites and ligands were predicted by a template-based method GalaxySite (<xref rid="B18" ref-type="bibr">18</xref>), covering 24,691 different ligands. For more effective binding prediction, only the structural domains predicted with higher confidence were considered. This database provides ligand binding site prediction for 16,554 unique human protein UniProt entries, covering 80.74% of the human proteome. The predicted binding sites and ligands could serve as a useful resource for further functional studies or drug discovery for previously unexplored proteins (<xref rid="B19" ref-type="bibr">19</xref>). HProteome-BSite is freely available at <ext-link xlink:href="https://galaxy.seoklab.org/hproteome-bsite/database" ext-link-type="uri">https://galaxy.seoklab.org/hproteome-bsite/database</ext-link> with a user-friendly interface and a help page that can guide non-expert users.</p>
  </sec>
  <sec sec-type="methods" id="SEC2">
    <title>METHODS FOR DATA PREPARATION</title>
    <sec id="SEC2-1">
      <title>Curation of the 3D human proteome</title>
      <p>The HProteome-BSite database provides binding information on the AlphaFold human proteome database. Since many AF structures contain low-quality regions, the structures were processed into high-quality domains before binding prediction, as shown in Figure <xref rid="F1" ref-type="fig">1</xref>. First, low-quality regions of longer than 10 consecutive residues with residue-wise pLDDT &lt;70 (<xref rid="B20" ref-type="bibr">20</xref>,<xref rid="B21" ref-type="bibr">21</xref>) were deleted, producing multiple fragments. Second, fragments with high inter-fragment contacts compared to intra-fragment contacts were merged. Finally, high-quality fragments were assigned as domains based on size and contact density. Further details on the domain assignment process are provided in <xref rid="sup1" ref-type="supplementary-material">Supplementary Method <bold>SM 1</bold></xref>. This curation of the structure database can increase the performance of binding prediction, as discussed below.</p>
      <fig position="float" id="F1">
        <label>Figure 1.</label>
        <caption>
          <p>Domains of high-quality structures are assigned after removing low-quality regions. In this example, three domains are assigned after deleting four low-quality regions.</p>
        </caption>
        <graphic xlink:href="gkac873fig1" position="float"/>
      </fig>
    </sec>
    <sec id="SEC2-2">
      <title>Prediction of ligand binding sites</title>
      <p>Ligand binding sites, potential ligands, and binding poses were predicted for each of the processed domain structures from the curated 3D human proteome using an updated version of GalaxySite (<xref rid="B18" ref-type="bibr">18</xref>), as outlined in Figure <xref rid="F2" ref-type="fig">2</xref>. Updates made to GalaxySite are described in detail in <xref rid="sup1" ref-type="supplementary-material">Supplementary Method <bold>SM 2</bold></xref>. Interaction templates to the query protein are detected by both sequence- and structure-based searches on the interaction template database. This database was curated in-house from the protein-ligand complex structures in PDB, as described in <bold>SM 2</bold>. The sequence-based method used the sequence alignment score HHscore (<xref rid="B21" ref-type="bibr">21</xref>), and the structure-based search used the structure alignment score TM-score to select interaction templates from the database. The binding sites and ligands were taken from the top-ranking templates. Binding poses were predicted by the protein-ligand docking program GalaxyDock2 (<xref rid="B22" ref-type="bibr">22</xref>) using the interaction restraints extracted from the template complex structures (<xref rid="B18" ref-type="bibr">18</xref>).</p>
      <fig position="float" id="F2">
        <label>Figure 2.</label>
        <caption>
          <p>Outline of GalaxySite binding prediction on the AlphaFold human structure database.</p>
        </caption>
        <graphic xlink:href="gkac873fig2" position="float"/>
      </fig>
      <p>The performance of the updated GalaxySite was tested on a benchmark set called COACH420 set (<xref rid="B23" ref-type="bibr">23</xref>), a subset of COACH (<xref rid="B24" ref-type="bibr">24</xref>,<xref rid="B25" ref-type="bibr">25</xref>) which consists of 420 single-chain protein targets. GalaxySite was run on the benchmark mode, discarding templates with sequence identity higher than 70% to the target from the interaction template database. The high sequence identity was chosen because a large fraction of proteins in the curated AFDB have protein-ligand complex templates of high similarity (median TMscore of 0.76, median sequence identity of 0.32). The protein crystal structures were used as input for the structure-based site prediction method in this binding site prediction test. The performance of GalaxySite was enhanced by the current update from 74% to 88% on the COACH420 set when a protein-wise success rate is considered, as shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table <bold>ST 1</bold></xref>. The performance increased slightly when the sequence- and structure-based search methods were combined.</p>
      <p>The ligand binding poses obtained by docking can be different from those of templates, and the distribution of the ligand RMSD between the ligand pose aligned to the template and the predicted ligand pose is shown in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure <bold>SF 1</bold>A</xref>. An example where the ligand pose deviation after docking is large is also presented <bold>SF 1</bold>B and C.</p>
    </sec>
    <sec id="SEC2-3">
      <title>Database statistics</title>
      <p>Out of 20 504 UniProt entries in the AlphaFold human proteome DB, HProteome-BSite provides ligand binding site predictions for 16 554 entries, which correspond to a coverage of 80.7%. Among the entries not included in the database, 60.5% of the entries were excluded due to low model quality resulting in no structural domain with high confidence. Our database provides binding site information for 95% of the entries with at least a single assigned structural domain. The binding site information also includes possible interacting ligands with an average (median) of 41.5 (14.0) ligands per entry. The proteins with predicted interactions in HProteome-BSite cover diverse protein families with high coverage, GPCRs (98.7%), ion channels (96.9%), kinases (99.5%), nuclear hormone receptors (96.8%) and proteases (99.2%). About 70% of human drugs on the market target GPCRs, ion channels, kinases and nuclear hormone receptors (<xref rid="B26" ref-type="bibr">26</xref>). The predicted interactions could aid further functional studies and drug developments targeting these proteins.</p>
    </sec>
  </sec>
  <sec id="SEC3">
    <title>UTILIZING THE DATABASE</title>
    <p>All predictions in the HProteome-BSite database can be accessed through the website <ext-link xlink:href="https://galaxy.seoklab.org/hproteome-bsite/database" ext-link-type="uri">https://galaxy.seoklab.org/hproteome-bsite/database</ext-link> which runs on all modern browsers. The website provides a search engine for finding proteins of interest, pages containing statistics of the database, and a help section about using the database. It also supports the visualization of protein structure and binding pose of potential ligands using Mol* (<xref rid="B27" ref-type="bibr">27</xref>) and a WebGL-based viewer PV (<ext-link xlink:href="https://biasmv.github.io/pv/" ext-link-type="uri">https://biasmv.github.io/pv/</ext-link>). The viewer also runs on phone and tablet screens without the need for additional plugins.</p>
    <p>Each entry in the database corresponds to an interaction prediction on each structural domain of the query protein. For each entry, information on the binding sites and ligands is provided, along with information on the interaction templates used for the prediction. As a measure of the reliability of the prediction, the structure similarity score (TM-score) of the query structure to the template protein structure is also given. For the top three binding sites predicted from each of the sequence-based and the structure-based search, the protein-ligand docking results of representative ligands are provided. Alternative ligands that were predicted to bind to the same binding sites are listed in addition, and a further binding pose prediction for those ligands is possible by submitting a docking run through a provided link to the docking web server within the same system.</p>
    <sec id="SEC3-1">
      <title>Searching for proteins of interest</title>
      <p>The search engine allows users to search for proteins of interest by UniProt ID or protein name. Proteins belonging to key protein families (GPCRs, proteases, kinases, nuclear hormone receptors, and ion channels) can also be browsed. The search results page shows a list of UniProt IDs for each search, as shown in Figure <xref rid="F3" ref-type="fig">3</xref>. Each UniProt ID is linked to a report page containing a list of binding predictions on individual structural domains. Each domain can be identified by a unique entry title composed of its UniProt ID, AF structure fragment number, and domain number (e.g. Q8TB40_F1_d1).</p>
      <fig position="float" id="F3">
        <label>Figure 3.</label>
        <caption>
          <p>A search example on the HProteome-BSite database. Proteins of interest can be searched for by UniProt ID, protein name, or protein family (left panel). If multiple targets match the search keyword, a list of all matching UniProt IDs is given on the search results page (upper right panel). Clicking on the UniProt ID leads to a report page showing a list of structural domains for which binding predictions are available (lower right panel).</p>
        </caption>
        <graphic xlink:href="gkac873fig3" position="float"/>
      </fig>
    </sec>
    <sec id="SEC3-2">
      <title>Interpreting the report page</title>
      <p>The report page for each entry provides information on predicted binding sites on the structural domain. Each page contains a 3D structure viewer that shows a protein structure (when the ‘See structural domain only’ is clicked) or a protein–ligand complex structure (when the ‘View on PV’ link of a representative ligand is clicked), as shown in the left panel of Figure <xref rid="F4" ref-type="fig">4</xref>. Detailed view of the complex structure using Mol* which allows visualization of interactions between the ligand and the protein is available on a separate page (when the ‘See Ligand Details (Mol*)’ link is clicked). The ligand details page (Figure <bold>SF 5</bold>) shows all available information on that specific ligand. The AF protein structure and the predicted protein-ligand complex structure can be downloaded in PDB and MOL2 format, respectively. A table of the maximum top 10 predicted binding sites for each of the sequence-based and structure-based searches is provided (upper right panel of Figure <xref rid="F4" ref-type="fig">4</xref>). Lists of full predictions can be downloaded in CSV format through the links below the tables (lower right panel of Figure <xref rid="F4" ref-type="fig">4</xref>). Each row of the table corresponds to a predicted binding site, with information on a representative ligand (with a predicted docking pose for the top three binding sites), templates used to predict ligands (with TM-score, which can be considered as a confidence measure), and alternative ligands. For the lower-rank representative ligands, docking poses were not pre-calculated, but docking can be run by clicking on the template name. For alternative ligands, docking can be run on the docking web server within the system (<ext-link xlink:href="https://galaxy.seoklab.org/cgi-bin/submit.cgi?type=SITE_DOCK" ext-link-type="uri">https://galaxy.seoklab.org/cgi-bin/submit.cgi?type=SITE_DOCK</ext-link>) using the provided information on the ligand, the protein domain, and the interaction template. A detailed explanation of how to interpret the results on the report page is also available on the website for the example shown in Figure <xref rid="F4" ref-type="fig">4</xref>. (<ext-link xlink:href="https://galaxy.seoklab.org/hproteome-bsite/database/help_result" ext-link-type="uri">https://galaxy.seoklab.org/hproteome-bsite/database/help_result</ext-link>).</p>
      <fig position="float" id="F4">
        <label>Figure 4.</label>
        <caption>
          <p>An example report page for the entry Q9H0K1_F1_d1 (<ext-link xlink:href="https://galaxy.seoklab.org/hproteome-bsite/database/domains/39056" ext-link-type="uri">https://galaxy.seoklab.org/hproteome-bsite/database/domains/39056</ext-link>).</p>
        </caption>
        <graphic xlink:href="gkac873fig4" position="float"/>
      </fig>
    </sec>
  </sec>
  <sec id="SEC4">
    <title>CASE STUDIES</title>
    <p><italic toggle="yes">Salt-Inducible Kinase 2 (SIK2)</italic>. Salt-inducible kinase 2 (UniProt ID Q9H0K1) is an AMP-activated protein kinase-related protein kinase that has been proposed as a target for ovarian cancer therapy (<xref rid="B28" ref-type="bibr">28</xref>,<xref rid="B29" ref-type="bibr">29</xref>). Despite its therapeutic importance, its structure has not been resolved by experiments. Two structural domains were compiled in our database, corresponding to residues 14–273 and 295–341, where the first domain was highly similar to that of the known kinase domain of SIK2 (residues 20–271). While the full protein structure deposited in the AlphaFold human proteome DB has a very low median pLDDT of 41.8, the first domain in our database shows a high median pLDDT of 95.0 (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure <bold>SF 2</bold></xref>). This example illustrates that the structure processing step could retrieve functional domains with high confidence even when the overall AF structure is of low quality.</p>
    <p>The top 1 predicted binding site for the kinase domain of SIK2 (residues 14–273) from both the structure- and sequence-based methods corresponds to the known ATP binding site of SIK2. To confirm this, a known inhibitor of SIK2 targeting the ATP binding site, HG-9–91-01, was docked using GalaxyDock3 (<xref rid="B30" ref-type="bibr">30</xref>) to the identified binding site. The docking results showed interactions consistent with previous findings that HG-9–91-01 targets not only the ATP-binding site of SIK2 with K49 as key residue but also a small hydrophobic pocket near the active site created by the presence of T96 at the gatekeeper site (<xref rid="B31" ref-type="bibr">31</xref>) (<xref rid="sup1" ref-type="supplementary-material">Supplementary Figure <bold>SF 3</bold></xref>).</p>
    <p><italic toggle="yes">Diacylglycerol O-acyltransferase 2 (DGAT2)</italic>. DGAT2 (UniProt ID Q96PD7) is a therapeutic target related to liver disease without any 3D structure resolved by experiments (<xref rid="B32" ref-type="bibr">32</xref>). This target was highlighted earlier as one of the useful predictions in the AlphaFold human proteome paper (<xref rid="B33" ref-type="bibr">33</xref>). In our database, the binding pocket of DGAT2 was successfully predicted by the structure-based search. When a known inhibitor, PF-06424439 (<xref rid="B34" ref-type="bibr">34</xref>), was docked to the binding site of the top-ranked ligand, the known key interactions between DGAT2 and the ligand involving residues H163, T194 and S244 were reproduced (<xref rid="B33" ref-type="bibr">33</xref>,<xref rid="B35" ref-type="bibr">35</xref>), as illustrated in <xref rid="sup1" ref-type="supplementary-material">Supplementary Figure <bold>SF 4</bold></xref>.</p>
  </sec>
  <sec sec-type="conclusions" id="SEC5">
    <title>CONCLUSION</title>
    <p>A new database HProteome-BSite provides predictions of binding sites, potential ligands and binding poses of the ligands on human proteome structures predicted by AlphaFold. An updated version of GalaxySite was employed to enhance the binding site prediction performance. The 3D human proteome was curated to retrieve structural domains of high confidence to facilitate binding site prediction and ligand docking. The HProteome-Bsite database provides at least a single binding site prediction for 81% of the human proteome, accounting for 95% of moderately accurate AF structures.</p>
    <p>Further improvements in the database would be possible through advanced protein structure prediction and binding prediction in the future. Currently, 25% of AlphaFold human protein structures are of low quality (median pLDDT &lt; 70), and many structures are only partially resolved. The accuracy of template-based and template-free binding prediction would be improved by employing deep learning techniques, especially with increasing interaction data generated by both experiments and predictions.</p>
    <p>Structural information on the ligand binding site of a protein can provide insights into the potential binding partners and their interactions with the protein. The information deposited in the HProteome-Bsite database would be useful for various applications, including protein functional study and drug discovery for previously unexplored proteins.</p>
  </sec>
  <sec sec-type="data-availability" id="SEC6">
    <title>DATA AVAILABILITY</title>
    <p>All predicted interaction information in HProteome-BSite is freely accessible at <ext-link xlink:href="https://seoklab.galaxy.org/hproteome-bsite/database" ext-link-type="uri">https://seoklab.galaxy.org/hproteome-bsite/database</ext-link>. The website is accessible and legible on both phone and tablet screens.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>gkac873_Supplemental_File</label>
      <media xlink:href="gkac873_supplemental_file.pdf">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec id="SEC7">
    <title>SUPPLEMENTARY DATA</title>
    <p><ext-link xlink:href="https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/gkac873#supplementary-data" ext-link-type="uri">Supplementary Data</ext-link> are available at NAR Online.</p>
  </sec>
  <sec id="SEC8">
    <title>FUNDING</title>
    <p>National Research Foundation of Korea (NRF) grants funded by the Korean government [2020M3A9G7103933]; Institute of Information &amp; communications Technology Planning &amp; Evaluation (IITP) grant funded by the Korean government (MSIT) [2021-0-02068, Artificial Intelligence Innovation Hub]; Samsung Science and Technology Foundation [SSTF-BA1901-08]. Funding for open access charge: Seoul National University.</p>
    <p><italic toggle="yes">Conflict of interest statement</italic>. None declared.</p>
  </sec>
  <ref-list id="REF1">
    <title>REFERENCES</title>
    <ref id="B1">
      <label>1.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jumper</surname><given-names>J.</given-names></string-name>, <string-name><surname>Evans</surname><given-names>R.</given-names></string-name>, <string-name><surname>Pritzel</surname><given-names>A.</given-names></string-name>, <string-name><surname>Green</surname><given-names>T.</given-names></string-name>, <string-name><surname>Figurnov</surname><given-names>M.</given-names></string-name>, <string-name><surname>Ronneberger</surname><given-names>O.</given-names></string-name>, <string-name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bates</surname><given-names>R.</given-names></string-name>, <string-name><surname>Zidek</surname><given-names>A.</given-names></string-name>, <string-name><surname>Potapenko</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Highly accurate protein structure prediction with alphafold</article-title>. <source>Nature</source>. <year>2021</year>; <volume>596</volume>:<fpage>583</fpage>–<lpage>589</lpage>.<pub-id pub-id-type="pmid">34265844</pub-id></mixed-citation>
    </ref>
    <ref id="B2">
      <label>2.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Baek</surname><given-names>M.</given-names></string-name>, <string-name><surname>DiMaio</surname><given-names>F.</given-names></string-name>, <string-name><surname>Anishchenko</surname><given-names>I.</given-names></string-name>, <string-name><surname>Dauparas</surname><given-names>J.</given-names></string-name>, <string-name><surname>Ovchinnikov</surname><given-names>S.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>G.R.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cong</surname><given-names>Q.</given-names></string-name>, <string-name><surname>Kinch</surname><given-names>L.N.</given-names></string-name>, <string-name><surname>Schaeffer</surname><given-names>R.D.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Accurate prediction of protein structures and interactions using a three-track neural network</article-title>. <source>Science</source>. <year>2021</year>; <volume>373</volume>:<fpage>871</fpage>–<lpage>876</lpage>.<pub-id pub-id-type="pmid">34282049</pub-id></mixed-citation>
    </ref>
    <ref id="B3">
      <label>3.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Varadi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Anyango</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Nair</surname><given-names>S.</given-names></string-name>, <string-name><surname>Natassia</surname><given-names>C.</given-names></string-name>, <string-name><surname>Yordanova</surname><given-names>G.</given-names></string-name>, <string-name><surname>Yuan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Stroe</surname><given-names>O.</given-names></string-name>, <string-name><surname>Wood</surname><given-names>G.</given-names></string-name>, <string-name><surname>Laydon</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D439</fpage>–<lpage>D444</lpage>.<pub-id pub-id-type="pmid">34791371</pub-id></mixed-citation>
    </ref>
    <ref id="B4">
      <label>4.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Modi</surname><given-names>V.</given-names></string-name>, <string-name><surname>Dunbrack</surname><given-names>R.L.</given-names></string-name></person-group><article-title>Kincore: a web resource for structural classification of protein kinases and their inhibitors</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D654</fpage>–<lpage>D664</lpage>.<pub-id pub-id-type="pmid">34643709</pub-id></mixed-citation>
    </ref>
    <ref id="B5">
      <label>5.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rodriguez</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Pozo</surname><given-names>F.</given-names></string-name>, <string-name><surname>Cerdan-Velez</surname><given-names>D.</given-names></string-name>, <string-name><surname>Di Domenico</surname><given-names>T.</given-names></string-name>, <string-name><surname>Vazquez</surname><given-names>J.</given-names></string-name>, <string-name><surname>Tress</surname><given-names>M.L.</given-names></string-name></person-group><article-title>APPRIS: selecting functionally important isoforms</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>D54</fpage>–<lpage>D59</lpage>.<pub-id pub-id-type="pmid">34755885</pub-id></mixed-citation>
    </ref>
    <ref id="B6">
      <label>6.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhao</surname><given-names>J.</given-names></string-name>, <string-name><surname>Cao</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>L.</given-names></string-name></person-group><article-title>Exploring the computational methods for protein-ligand binding site prediction</article-title>. <source>Comput. Struct. Biotechnol. J.</source><year>2020</year>; <volume>18</volume>:<fpage>417</fpage>–<lpage>426</lpage>.<pub-id pub-id-type="pmid">32140203</pub-id></mixed-citation>
    </ref>
    <ref id="B7">
      <label>7.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Burley</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Bhikadiya</surname><given-names>C.</given-names></string-name>, <string-name><surname>Bi</surname><given-names>C.</given-names></string-name>, <string-name><surname>Bittrich</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chen</surname><given-names>L.</given-names></string-name>, <string-name><surname>Crichlow</surname><given-names>G.V.</given-names></string-name>, <string-name><surname>Christie</surname><given-names>C.H.</given-names></string-name>, <string-name><surname>Dalenberg</surname><given-names>K.</given-names></string-name>, <string-name><surname>Di Costanzo</surname><given-names>L.</given-names></string-name>, <string-name><surname>Duarte</surname><given-names>J.M.</given-names></string-name><etal>et al</etal>.</person-group><article-title>RCSB protein data bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>D437</fpage>–<lpage>D451</lpage>.<pub-id pub-id-type="pmid">33211854</pub-id></mixed-citation>
    </ref>
    <ref id="B8">
      <label>8.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Li</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Han</surname><given-names>L.</given-names></string-name>, <string-name><surname>Li</surname><given-names>J.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhao</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Nie</surname><given-names>W.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Wang</surname><given-names>R.</given-names></string-name></person-group><article-title>PDB-wide collection of binding data: current status of the PDBbind database</article-title>. <source>Bioinformatics</source>. <year>2015</year>; <volume>31</volume>:<fpage>405</fpage>–<lpage>412</lpage>.<pub-id pub-id-type="pmid">25301850</pub-id></mixed-citation>
    </ref>
    <ref id="B9">
      <label>9.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Roy</surname><given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name></person-group><article-title>BioLiP: a semi-manually curated database for biologically relevant ligand-protein interactions</article-title>. <source>Nucleic Acids Res.</source><year>2013</year>; <volume>41</volume>:<fpage>D1096</fpage>–<lpage>D1103</lpage>.<pub-id pub-id-type="pmid">23087378</pub-id></mixed-citation>
    </ref>
    <ref id="B10">
      <label>10.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Smith</surname><given-names>R.D.</given-names></string-name>, <string-name><surname>Clark</surname><given-names>J.J.</given-names></string-name>, <string-name><surname>Ahmed</surname><given-names>A.</given-names></string-name>, <string-name><surname>Orban</surname><given-names>Z.J.</given-names></string-name>, <string-name><surname>Dunbar</surname><given-names>J.B.</given-names><suffix>Jr</suffix></string-name>, <string-name><surname>Carlson</surname><given-names>H.A</given-names></string-name></person-group><article-title>Updates to binding MOAD (Mother of all databases): polypharmacology tools and their utility in drug repurposing</article-title>. <source>J. Mol. Biol.</source><year>2019</year>; <volume>431</volume>:<fpage>2423</fpage>–<lpage>2433</lpage>.<pub-id pub-id-type="pmid">31125569</pub-id></mixed-citation>
    </ref>
    <ref id="B11">
      <label>11.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Desaphy</surname><given-names>J.</given-names></string-name>, <string-name><surname>Bret</surname><given-names>G.</given-names></string-name>, <string-name><surname>Rognan</surname><given-names>D.</given-names></string-name>, <string-name><surname>Kellenberger</surname><given-names>E.</given-names></string-name></person-group><article-title>sc-PDB: a 3D-database of ligandable binding sites–10 years on</article-title>. <source>Nucleic Acids Res.</source><year>2015</year>; <volume>43</volume>:<fpage>D399</fpage>–<lpage>D404</lpage>.<pub-id pub-id-type="pmid">25300483</pub-id></mixed-citation>
    </ref>
    <ref id="B12">
      <label>12.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bhagavat</surname><given-names>R.</given-names></string-name>, <string-name><surname>Sankar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Srinivasan</surname><given-names>N.</given-names></string-name>, <string-name><surname>Chandra</surname><given-names>N.</given-names></string-name></person-group><article-title>An augmented pocketome: detection and analysis of small-molecule binding pockets in proteins of known 3D structure</article-title>. <source>Structure</source>. <year>2018</year>; <volume>26</volume>:<fpage>499</fpage>–<lpage>512</lpage>.<pub-id pub-id-type="pmid">29514079</pub-id></mixed-citation>
    </ref>
    <ref id="B13">
      <label>13.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Konc</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lesnik</surname><given-names>S.</given-names></string-name>, <string-name><surname>Skrlj</surname><given-names>B.</given-names></string-name>, <string-name><surname>Janezic</surname><given-names>D</given-names></string-name></person-group><article-title>ProBiS-Dock database: a web server and interactive web repository of small ligand-protein binding sites for drug design</article-title>. <source>J. Chem. Inf. Model.</source><year>2021</year>; <volume>61</volume>:<fpage>4097</fpage>–<lpage>4107</lpage>.<pub-id pub-id-type="pmid">34319727</pub-id></mixed-citation>
    </ref>
    <ref id="B14">
      <label>14.</label>
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Hekkelman</surname><given-names>M.L.</given-names></string-name>, <string-name><surname>de Vries</surname><given-names>I.</given-names></string-name>, <string-name><surname>Joosten</surname><given-names>R.P.</given-names></string-name>, <string-name><surname>Perrakis</surname><given-names>A.</given-names></string-name></person-group><article-title>AlphaFill: enriching the alphafold models with ligands and co-factors</article-title>. <year>2021</year>; <comment>bioRxiv doi:</comment><comment>27 November 2021, preprint: not peer reviewed</comment><pub-id pub-id-type="doi">10.1101/2021.11.26.470110</pub-id>.</mixed-citation>
    </ref>
    <ref id="B15">
      <label>15.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>S.</given-names></string-name>, <string-name><surname>Lin</surname><given-names>H.</given-names></string-name>, <string-name><surname>Huang</surname><given-names>Z.</given-names></string-name>, <string-name><surname>He</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Deng</surname><given-names>X.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Pei</surname><given-names>J.</given-names></string-name>, <string-name><surname>Lai</surname><given-names>L.</given-names></string-name></person-group><article-title>CavitySpace: a database of potential ligand binding sites in the human proteome</article-title>. <source>Biomolecules</source>. <year>2022</year>; <volume>12</volume>:<fpage>967</fpage>.<pub-id pub-id-type="pmid">35883523</pub-id></mixed-citation>
    </ref>
    <ref id="B16">
      <label>16.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jakubec</surname><given-names>D.</given-names></string-name>, <string-name><surname>Skoda</surname><given-names>P.</given-names></string-name>, <string-name><surname>Krivak</surname><given-names>R.</given-names></string-name>, <string-name><surname>Novotny</surname><given-names>M.</given-names></string-name>, <string-name><surname>Hoksza</surname><given-names>D</given-names></string-name></person-group><article-title>PrankWeb 3: accelerated ligand-binding site predictions for experimental and modelled protein structures</article-title>. <source>Nucleic Acids Res.</source><year>2022</year>; <volume>50</volume>:<fpage>W593</fpage>–<lpage>W597</lpage>.</mixed-citation>
    </ref>
    <ref id="B17">
      <label>17.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tubiana</surname><given-names>J.</given-names></string-name>, <string-name><surname>Schneidman-Duhovny</surname><given-names>D.</given-names></string-name>, <string-name><surname>Wolfson</surname><given-names>H.J.</given-names></string-name></person-group><article-title>ScanNet: an interpretable geometric deep learning model for structure-based protein binding site prediction</article-title>. <source>Nat. Methods</source>. <year>2022</year>; <volume>19</volume>:<fpage>730</fpage>–<lpage>739</lpage>.<pub-id pub-id-type="pmid">35637310</pub-id></mixed-citation>
    </ref>
    <ref id="B18">
      <label>18.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Heo</surname><given-names>L.</given-names></string-name>, <string-name><surname>Shin</surname><given-names>W.H.</given-names></string-name>, <string-name><surname>Lee</surname><given-names>M.S.</given-names></string-name>, <string-name><surname>Seok</surname><given-names>C.</given-names></string-name></person-group><article-title>GalaxySite: ligand-binding-site prediction by using molecular docking</article-title>. <source>Nucleic Acids Res.</source><year>2014</year>; <volume>42</volume>:<fpage>W210</fpage>–<lpage>W214</lpage>.<pub-id pub-id-type="pmid">24753427</pub-id></mixed-citation>
    </ref>
    <ref id="B19">
      <label>19.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Naderi</surname><given-names>M.</given-names></string-name>, <string-name><surname>Lemoine</surname><given-names>J.M.</given-names></string-name>, <string-name><surname>Govindaraj</surname><given-names>R.G.</given-names></string-name>, <string-name><surname>Kana</surname><given-names>O.Z.</given-names></string-name>, <string-name><surname>Feinstein</surname><given-names>W.P.</given-names></string-name>, <string-name><surname>Brylinski</surname><given-names>M.</given-names></string-name></person-group><article-title>Binding site matching in rational drug design: algorithms and applications</article-title>. <source>Brief. Bioinform</source>. <year>2019</year>; <volume>20</volume>:<fpage>2167</fpage>–<lpage>2184</lpage>.<pub-id pub-id-type="pmid">30169563</pub-id></mixed-citation>
    </ref>
    <ref id="B20">
      <label>20.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mariani</surname><given-names>V.</given-names></string-name>, <string-name><surname>Biasini</surname><given-names>M.</given-names></string-name>, <string-name><surname>Barbato</surname><given-names>A.</given-names></string-name>, <string-name><surname>Schwede</surname><given-names>T.</given-names></string-name></person-group><article-title>lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>2722</fpage>–<lpage>2728</lpage>.<pub-id pub-id-type="pmid">23986568</pub-id></mixed-citation>
    </ref>
    <ref id="B21">
      <label>21.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soding</surname><given-names>J.</given-names></string-name></person-group><article-title>Protein homology detection by HMM-HMM comparison</article-title>. <source>Bioinformatics</source>. <year>2005</year>; <volume>21</volume>:<fpage>951</fpage>–<lpage>960</lpage>.<pub-id pub-id-type="pmid">15531603</pub-id></mixed-citation>
    </ref>
    <ref id="B22">
      <label>22.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shin</surname><given-names>W.H.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>J.K.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>D.S.</given-names></string-name>, <string-name><surname>Seok</surname><given-names>C.</given-names></string-name></person-group><article-title>GalaxyDock2: protein-ligand docking using beta-complex and global optimization</article-title>. <source>J. Comput. Chem.</source><year>2013</year>; <volume>34</volume>:<fpage>2647</fpage>–<lpage>2656</lpage>.<pub-id pub-id-type="pmid">24108416</pub-id></mixed-citation>
    </ref>
    <ref id="B23">
      <label>23.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Krivak</surname><given-names>R.</given-names></string-name>, <string-name><surname>Hoksza</surname><given-names>D</given-names></string-name></person-group><article-title>P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure</article-title>. <source>J. Cheminform.</source><year>2018</year>; <volume>10</volume>:<fpage>39</fpage>.<pub-id pub-id-type="pmid">30109435</pub-id></mixed-citation>
    </ref>
    <ref id="B24">
      <label>24.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Roy</surname><given-names>A.</given-names></string-name>, <string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name></person-group><article-title>COFACTOR: an accurate comparative algorithm for structure-based protein function annotation</article-title>. <source>Nucleic Acids Res.</source><year>2012</year>; <volume>40</volume>:<fpage>W471</fpage>–<lpage>W477</lpage>.<pub-id pub-id-type="pmid">22570420</pub-id></mixed-citation>
    </ref>
    <ref id="B25">
      <label>25.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Roy</surname><given-names>A.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>Y.</given-names></string-name></person-group><article-title>Protein-ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment</article-title>. <source>Bioinformatics</source>. <year>2013</year>; <volume>29</volume>:<fpage>2588</fpage>–<lpage>2595</lpage>.<pub-id pub-id-type="pmid">23975762</pub-id></mixed-citation>
    </ref>
    <ref id="B26">
      <label>26.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Santos</surname><given-names>R.</given-names></string-name>, <string-name><surname>Ursu</surname><given-names>O.</given-names></string-name>, <string-name><surname>Gaulton</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bento</surname><given-names>A.P.</given-names></string-name>, <string-name><surname>Donadi</surname><given-names>R.S.</given-names></string-name>, <string-name><surname>Bologa</surname><given-names>C.G.</given-names></string-name>, <string-name><surname>Karlsson</surname><given-names>A.</given-names></string-name>, <string-name><surname>Al-Lazikani</surname><given-names>B.</given-names></string-name>, <string-name><surname>Hersey</surname><given-names>A.</given-names></string-name>, <string-name><surname>Oprea</surname><given-names>T.I.</given-names></string-name><etal>et al</etal>.</person-group><article-title>A comprehensive map of molecular drug targets</article-title>. <source>Nat. Rev. Drug Discov.</source><year>2017</year>; <volume>16</volume>:<fpage>19</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">27910877</pub-id></mixed-citation>
    </ref>
    <ref id="B27">
      <label>27.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sehnal</surname><given-names>D.</given-names></string-name>, <string-name><surname>Bittrich</surname><given-names>S.</given-names></string-name>, <string-name><surname>Deshpande</surname><given-names>M.</given-names></string-name>, <string-name><surname>Svobodová</surname><given-names>R.</given-names></string-name>, <string-name><surname>Berka</surname><given-names>K.</given-names></string-name>, <string-name><surname>Bazgier</surname><given-names>V.</given-names></string-name>, <string-name><surname>Velankar</surname><given-names>S.</given-names></string-name>, <string-name><surname>Burley</surname><given-names>S.K.</given-names></string-name>, <string-name><surname>Koča</surname><given-names>J.</given-names></string-name>, <string-name><surname>Rose</surname><given-names>A.S.</given-names></string-name></person-group><article-title>Mol* viewer: modern web app for 3D visualization and analysis of large biomolecular structures</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>; <volume>49</volume>:<fpage>W431</fpage>–<lpage>W437</lpage>.<pub-id pub-id-type="pmid">33956157</pub-id></mixed-citation>
    </ref>
    <ref id="B28">
      <label>28.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><collab>Australian Ovarian Cancer Study Group</collab><string-name><surname>Ahmed</surname><given-names>A.A.</given-names></string-name>, <string-name><surname>Lu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Jennings</surname><given-names>N.B.</given-names></string-name>, <string-name><surname>Etemadmoghadam</surname><given-names>D.</given-names></string-name>, <string-name><surname>Capalbo</surname><given-names>L.</given-names></string-name>, <string-name><surname>Jacamo</surname><given-names>R.O.</given-names></string-name>, <string-name><surname>Barbosa-Morais</surname><given-names>N.</given-names></string-name>, <string-name><surname>Le</surname><given-names>X.F.</given-names></string-name>, <string-name><surname>Vivas-Mejia</surname><given-names>P.</given-names></string-name><etal>et al</etal>.</person-group><article-title>SIK2 is a centrosome kinase required for bipolar mitotic spindle formation that provides a potential target for therapy in ovarian cancer</article-title>. <source>Cancer Cell</source>. <year>2010</year>; <volume>18</volume>:<fpage>109</fpage>–<lpage>121</lpage>.<pub-id pub-id-type="pmid">20708153</pub-id></mixed-citation>
    </ref>
    <ref id="B29">
      <label>29.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miranda</surname><given-names>F.</given-names></string-name>, <string-name><surname>Mannion</surname><given-names>D.</given-names></string-name>, <string-name><surname>Liu</surname><given-names>S.</given-names></string-name>, <string-name><surname>Zheng</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Mangala</surname><given-names>L.S.</given-names></string-name>, <string-name><surname>Redondo</surname><given-names>C.</given-names></string-name>, <string-name><surname>Herrero-Gonzalez</surname><given-names>S.</given-names></string-name>, <string-name><surname>Xu</surname><given-names>R.</given-names></string-name>, <string-name><surname>Taylor</surname><given-names>C.</given-names></string-name>, <string-name><surname>Chedom</surname><given-names>D.F.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Salt-Inducible kinase 2 couples ovarian cancer cell metabolism with survival at the adipocyte-rich metastatic niche</article-title>. <source>Cancer Cell</source>. <year>2016</year>; <volume>30</volume>:<fpage>273</fpage>–<lpage>289</lpage>.<pub-id pub-id-type="pmid">27478041</pub-id></mixed-citation>
    </ref>
    <ref id="B30">
      <label>30.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Yang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Baek</surname><given-names>M.</given-names></string-name>, <string-name><surname>Seok</surname><given-names>C.</given-names></string-name></person-group><article-title>GalaxyDock3: Protein–ligand docking that considers the full ligand conformational flexibility</article-title>. <source>J. Comput. Chem.</source><year>2019</year>; <volume>40</volume>:<fpage>2739</fpage>–<lpage>2748</lpage>.<pub-id pub-id-type="pmid">31423613</pub-id></mixed-citation>
    </ref>
    <ref id="B31">
      <label>31.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Clark</surname><given-names>K.</given-names></string-name>, <string-name><surname>MacKenzie</surname><given-names>K.F.</given-names></string-name>, <string-name><surname>Petkevicius</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kristariyanto</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>J.</given-names></string-name>, <string-name><surname>Choi</surname><given-names>H.G.</given-names></string-name>, <string-name><surname>Peggie</surname><given-names>M.</given-names></string-name>, <string-name><surname>Plater</surname><given-names>L.</given-names></string-name>, <string-name><surname>Pedrioli</surname><given-names>P.G.</given-names></string-name>, <string-name><surname>McIver</surname><given-names>E.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Phosphorylation of CRTC3 by the salt-inducible kinases controls the interconversion of classically activated and regulatory macrophages</article-title>. <source>Proc. Natl. Acad. Sci. U.S.A.</source><year>2012</year>; <volume>109</volume>:<fpage>16986</fpage>–<lpage>16991</lpage>.<pub-id pub-id-type="pmid">23033494</pub-id></mixed-citation>
    </ref>
    <ref id="B32">
      <label>32.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Amin</surname><given-names>N.B.</given-names></string-name>, <string-name><surname>Carvajal-Gonzalez</surname><given-names>S.</given-names></string-name>, <string-name><surname>Purkal</surname><given-names>J.</given-names></string-name>, <string-name><surname>Zhu</surname><given-names>T.</given-names></string-name>, <string-name><surname>Crowley</surname><given-names>C.</given-names></string-name>, <string-name><surname>Perez</surname><given-names>S.</given-names></string-name>, <string-name><surname>Chidsey</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kim</surname><given-names>A.M.</given-names></string-name>, <string-name><surname>Goodwin</surname><given-names>B.</given-names></string-name></person-group><article-title>Targeting diacylglycerol acyltransferase 2 for the treatment of nonalcoholic steatohepatitis</article-title>. <source>Sci. Transl. Med.</source><year>2019</year>; <volume>11</volume>:<fpage>eaav9701</fpage>.<pub-id pub-id-type="pmid">31776293</pub-id></mixed-citation>
    </ref>
    <ref id="B33">
      <label>33.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tunyasuvunakool</surname><given-names>K.</given-names></string-name>, <string-name><surname>Adler</surname><given-names>J.</given-names></string-name>, <string-name><surname>Wu</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Green</surname><given-names>T.</given-names></string-name>, <string-name><surname>Zielinski</surname><given-names>M.</given-names></string-name>, <string-name><surname>Zidek</surname><given-names>A.</given-names></string-name>, <string-name><surname>Bridgland</surname><given-names>A.</given-names></string-name>, <string-name><surname>Cowie</surname><given-names>A.</given-names></string-name>, <string-name><surname>Meyer</surname><given-names>C.</given-names></string-name>, <string-name><surname>Laydon</surname><given-names>A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Highly accurate protein structure prediction for the human proteome</article-title>. <source>Nature</source>. <year>2021</year>; <volume>596</volume>:<fpage>590</fpage>–<lpage>596</lpage>.<pub-id pub-id-type="pmid">34293799</pub-id></mixed-citation>
    </ref>
    <ref id="B34">
      <label>34.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Futatsugi</surname><given-names>K.</given-names></string-name>, <string-name><surname>Kung</surname><given-names>D.W.</given-names></string-name>, <string-name><surname>Orr</surname><given-names>S.T.</given-names></string-name>, <string-name><surname>Cabral</surname><given-names>S.</given-names></string-name>, <string-name><surname>Hepworth</surname><given-names>D.</given-names></string-name>, <string-name><surname>Aspnes</surname><given-names>G.</given-names></string-name>, <string-name><surname>Bader</surname><given-names>S.</given-names></string-name>, <string-name><surname>Bian</surname><given-names>J.</given-names></string-name>, <string-name><surname>Boehm</surname><given-names>M.</given-names></string-name>, <string-name><surname>Carpino</surname><given-names>P.A.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Discovery and optimization of imidazopyridine-based inhibitors of diacylglycerol acyltransferase 2 (DGAT2)</article-title>. <source>J. Med. Chem.</source><year>2015</year>; <volume>58</volume>:<fpage>7173</fpage>–<lpage>7185</lpage>.<pub-id pub-id-type="pmid">26349027</pub-id></mixed-citation>
    </ref>
    <ref id="B35">
      <label>35.</label>
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wang</surname><given-names>L.</given-names></string-name>, <string-name><surname>Qian</surname><given-names>H.</given-names></string-name>, <string-name><surname>Nian</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Han</surname><given-names>Y.</given-names></string-name>, <string-name><surname>Ren</surname><given-names>Z.</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>H.</given-names></string-name>, <string-name><surname>Hu</surname><given-names>L.</given-names></string-name>, <string-name><surname>Prasad</surname><given-names>B.V.V.</given-names></string-name>, <string-name><surname>Laganowsky</surname><given-names>A.</given-names></string-name>, <string-name><surname>Yan</surname><given-names>N.</given-names></string-name><etal>et al</etal>.</person-group><article-title>Structure and mechanism of human diacylglycerol O-acyltransferase 1</article-title>. <source>Nature</source>. <year>2020</year>; <volume>581</volume>:<fpage>329</fpage>–<lpage>332</lpage>.<pub-id pub-id-type="pmid">32433610</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
